Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Norum-Krankheit

Die Norum-Krankheit ist eine autosomal rezessive Erkrankung die auf Mutationen des LCAT-Gens beruht. Die Erkrankung ist durch Hornhauttrübung, normochrome hämolytische Anämie und Schaumzellen im Knochenmark charakterisiert. Zu den typischen Laborbefunden zählen rhöhte Triglycerid-, Phospholipid und Cholestrolspiegel. Auch eine Proteinurie kann gefunden werden.

Pathogenese

Biochemisch ist diese Erkrankung durch einen kompletten Ausfall des Enzyms Lecithin-cholesterol acyltransferase (LCAT) gekennzeichnet. Das betrifft sowohl die Funktion an den kleinen HDL-Partikeln, wo das ApoA1 der den Enzymaktivator bildet, wie auch an den großen ApoB-enthaltenden Lipoproteinen.

Management

Die Therapie besteht in einer cholestrinarmen Diät und ggf. Bluttransfusionen zum Ausgleich der Anämie. Eine kausale Therapie ist mit der Lebertransplantation möglich.

Gliederung

Glomerulosklerose
Familiäre partielle Lipodystrophie Typ 2
Fokal segmentale Glomerulosklerose (FSGS)
Frasier-Syndrom
Glycogenspeicherkrankheit 1A
Norum-Krankheit
LCAT

Referenzen:

1.

Taramelli R et al. (1990) Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele.

external link
2.

Muthusethupathi MA et al. (1999) Familial Lecithin:cholesterol acyltransferase deficiency with renal failure in two siblings. First case report from India.

external link
3.

Ng DS et al. (1997) Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.

external link
4.

Sakai N et al. (1997) Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency.

external link
5.

Hoeg JM et al. (1996) Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.

external link
6.

Rader DJ et al. (1994) Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.

external link
7.

Albers JJ et al. (1981) Familial lecithin-cholesterol acyltransferase: identification of heterozygotes with half-normal enzyme activity and mass.

external link
8.

Utermann G et al. (1981) Lecithin-cholesterol-acyltransferase deficiency: autosomal recessive transmission in a large kindred.

external link
9.

Albers JJ et al. (1981) Genetic control of lecithin-cholesterol acyltransferase (LCAT): measurement of LCAT mass in a large kindred with LCAT deficiency.

external link
10.

Gjone E et al. (1981) Familial lecithin:cholesterol acyltransferase deficiency. Report of a fourth family from northwestern Norway.

external link
11.

Borysiewicz LK et al. (1982) Renal failure in familial lecithin: cholesterol acyltransferase deficiency.

external link
12.

Albers JJ et al. (1982) Familial lecithin-cholesterol acyltransferase deficiency in a Japanese family: evidence for functionally defective enzyme in homozygotes and obligate heterozygotes.

external link
13.

Sakuma M et al. (1982) Familial plasma lecithin: cholesterol acyltransferase deficiency. A new family with partial LCAT activity.

external link
14.

Teisberg P et al. (1981) Genetic heterogeneity in familial lecithin:cholesterol acyltransferase (LCAT) deficiency.

external link
15.

Gjone E et al. (1968) Familial plasma cholesterol ester deficiency. A study of the erythrocytes.

external link
16.

Gotoda T et al. (1991) Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency.

external link
17.

Humphries SE et al. (1988) A study of the structure of the gene for lecithin: cholesterol acyltransferase in four unrelated individuals with familial lecithin: cholesterol acyltransferase deficiency.

external link
18.

Norum KR et al. (1974) Lecithin: cholesterol acyltransferase recent research on biochemistry and physiology of the enzyme.

external link
19.

Norum KR et al. (1967) Familial serum-cholesterol esterification failure. A new inborn error of metabolism.

external link
20.

Vergani C et al. (1983) A new case of familial LCAT deficiency.

external link
21.

Teisberg P et al. (1975) Genetics of LCAT (lecithin: cholesterol acyltransferase) deficiency.

external link
22.

Frohlich J et al. (1982) Detection of heterozygotes for familial lecithin: cholesterol acyltransferase (LCAT) deficiency.

external link
23.

Weber P et al. (1987) Hereditary lecithin-cholesterol acyltransferase deficiency. Case report of a German patient.

external link
24.

Flatmark AL et al. (1977) Renal transplantation in patients with familial lecithin: cholesterol-acetyltransferase deficiency.

external link
25.

Teisberg P et al. (1974) Probable linkage of LCAT locus in man to the alpha haptoglobin locus on chromosome 16.

external link
26.

Nordöy A et al. (1971) Familial plasma lecithin: cholesterol acyltransferase deficiency. A study of the platelets.

external link
27.

Gjone E et al. () Familial serum cholesterol ester deficiency. Clinical study of a patient with a new syndrome.

external link
28.

Murayama N et al. (1984) Decreased sodium influx and abnormal red cell membrane lipids in a patient with familial plasma lecithin: cholesterol acyltransferase deficiency.

external link
29.

Orphanet article

Orphanet ID 650 external link
30.

OMIM.ORG article

Omim 245900 external link
31.

Wikipedia Artikel

Wikipedia DE (LCAT-Mangel) external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz